Grifols (GIFLF) Inventory (2009 - 2025)
Grifols' (GIFLF) quarterly Inventory came in at $3.8 billion in Q4 2025, up 0.85% on a YoY basis from $3.8 billion in Q4 2024, and up 0.85% quarter-over-quarter from $3.8 billion in Q4 2024.
Analysis
Grifols (GIFLF) Inventory (2009 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Inventory for 17 consecutive years, with $3.8 billion the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Inventory rose 0.85% year-over-year to $3.8 billion; the trailing twelve-month figure through Dec 2025 stood at $3.8 billion (up 0.85% YoY), and the FY2025 full-year result was $3.7 billion, down 2.11% from the prior year.
- Inventory grew to $3.8 billion in Q4 2025 per GIFLF's latest filing, from $3.8 billion in the prior quarter.
- Across five years, Inventory topped out at $3.8 billion in Q4 2025 and bottomed at $2.6 billion in Q4 2021.
- Historically, Inventory has averaged $3.5 billion across 5 years, with a median of $3.7 billion in 2023.
- The sharpest annual moves came in 2022 and 2025: Inventory increased 27.74% in 2022, then gained 0.85% in 2025.
- Over 5 years, Inventory stood at $2.6 billion in 2021, then increased by 27.74% to $3.3 billion in 2022, then climbed by 13.49% to $3.7 billion in 2023, then gained by 1.53% to $3.8 billion in 2024, then climbed by 0.85% to $3.8 billion in 2025.
- According to Business Quant data, Inventory over the past three periods registered $3.8 billion, $3.8 billion, and $3.7 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 6.22 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 1.95 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 3.08 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 371.00 Mn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 280.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 2.38 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | 3.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.84 Bn |
| Dec 31, 2024 | 3.80 Bn |
| Dec 31, 2023 | 3.75 Bn |
| Dec 31, 2022 | 3.30 Bn |
| Dec 31, 2021 | 2.58 Bn |
| Dec 31, 2020 | 2.39 Bn |
| Sep 30, 2020 | 2.32 Bn |
| Mar 31, 2020 | 2.72 Bn |
| Dec 31, 2019 | 2.59 Bn |
| Sep 30, 2019 | 2.59 Bn |
| Mar 31, 2019 | 2.40 Bn |
| Dec 31, 2018 | 2.22 Bn |
| Sep 30, 2018 | 2.17 Bn |
| Jun 30, 2018 | 2.16 Bn |
| Mar 31, 2018 | 2.06 Bn |
| Dec 31, 2017 | 1.92 Bn |
| Jun 30, 2017 | 1.75 Bn |
| Dec 31, 2016 | 1.77 Bn |
| Sep 30, 2016 | 1.72 Bn |
| Jun 30, 2016 | 1.73 Bn |